<DOC>
	<DOCNO>NCT02776098</DOCNO>
	<brief_summary>This study investigate link glucose abnormality elements critical muscle function include mass , composition energy metabolism . primary goal study determine whether Cystic Fibrosis ( CF ) disease associate muscle dysfunction , especially presence glucose intolerance . This longitudinal cohort study 3 main group : CF subject without Cystic Fibrosis-related diabetes ( CFRD ) , healthy match control CF subject newly diagnose CFRD start insulin therapy .</brief_summary>
	<brief_title>Muscle Accrual Function Cystic Fibrosis-Impact Glucose Intolerance</brief_title>
	<detailed_description>Cystic Fibrosis ( CF ) lethal inherited disease primarily affect lung also confers high risk diabetes , 40-50 % adult experience Cystic Fibrosis-related diabetes ( CFRD ) . CFRD associate accelerated decline lung function , nutritional status survival despite treatment mortality patient CFRD remain high . Airway inflammation susceptibility infection cause hyperglycemia , catabolic effect insulin deficiency posit mechanisms CFRD-associated morbidity . Respiratory failure cause airway disease well know contribution respiratory muscle dysfunction may critical . In Type 2 Diabetes Mellitus ( T2DM ) glucose insulin defect closely correlated muscle function . The pulmonary muscle crucial respiration airway clearance CF . Muscle function dependent mass , composition , energy metabolism . Lean body mass ( LBM ) deficits present CF improvement LBM improve pulmonary function . Using T2DM model muscle dysfunction , study hypothesis glucose intolerance exacerbates LBM deficit , negatively affect muscle composition , alters muscle metabolism lead respiratory muscle dysfunction decline pulmonary function . CF subject without CFRD healthy control undergo 3 study visit ( baseline annually 2 year ) CFRD subject undergo 2 study visit ( baseline 6 month baseline ) . Evaluations include neurologic exam , anthropometric assessment , 3-day dietary recall , MRI scan , oral glucose tolerance test ( CF subject ) , blood work , pulmonary function testing , muscle strength testing , exercise testing , bone density scan , adverse event assessment .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<criteria>Inclusion Criteria CF subject without CFRD : 1 . Males females age 16 22 year . 2 . Confirmed diagnosis CF per CF Foundation guideline 3 . Parental/guardian permission ( informed consent ) appropriate , child assent . Exclusion Criteria CF subject without CFRD 1 . Chronic systemic glucocorticoid use e.g . allergic bronchopulmonary aspergillosis 2 . Organ transplantation 3 . Forced Expiratory Volume ( FFEV ) 1 % predict &lt; 40 % 4 . Established diagnosis CFRD treatment insulin hypoglycemic agent 5 . Parents/guardians subject , opinion Investigator , may noncompliant study schedule procedure . 6 . Pregnancy breastfeeding ( female ) 7 . Preexisting neurological neuromuscular disease All study visit CF subject schedule period baseline health . Visits perform within 4 week acute respiratory illness pulmonary exacerbation . Inclusion Criteria healthy control 1 . Age , sex , ethnicity , BMImatched time enrollment CF subject without CFRD 2 . Parental/guardian permission ( informed consent ) appropriate , child assent . Exclusion Criteria healthy control 1 . Parents/guardians subject , opinion Investigator , may noncompliant study schedule procedure . 2 . Pregnancy breastfeeding ( female ) 3 . Preexisting neurological neuromuscular disease Inclusion Criteria CF subject new CFRD 1 . Males females age 12 year . 2 . Confirmed diagnosis CF per CF Foundation guideline . 3 . New diagnosis CFRD base ) clinically indicated oral glucose tolerance test ( OGTT ) b ) hyperglycemia ( plasma glucose &gt; 200 mg/dL ) persist &gt; 48 hour hospitalization and/or c ) elevate HemoglobinA1C ( HbA1C ) within 4 week diagnosis . 4 . Parental/guardian permission ( informed consent ) appropriate , child assent . Exclusion Criteria CF subject new CFRD 1 . Chronic systemic glucocorticoid use e.g . allergic bronchopulmonary aspergillosis 2 . Organ transplantation 3 . Parents/guardians subject , opinion Investigator , may noncompliant study schedule procedure . 4 . Pregnancy breastfeeding ( female ) 5 . Preexisting neurological neuromuscular disease</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Cystic Fibrosis</keyword>
	<keyword>Glucose Intolerance</keyword>
	<keyword>Muscle Accrual</keyword>
	<keyword>Cystic Fibrosis-related Diabetes</keyword>
</DOC>